Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) VP Elizabeth D. Phillips sold 1,557 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $17.56, for a total value of $27,340.92. Following the transaction, the vice president now directly owns 14,035 shares of the company’s stock, valued at approximately $246,454.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Kewaunee Scientific Stock Down 1.7 %
Shares of Kewaunee Scientific stock traded down $0.31 on Tuesday, reaching $17.92. 142 shares of the company were exchanged, compared to its average volume of 2,544. Kewaunee Scientific Co. has a one year low of $14.56 and a one year high of $19.15. The company has a market capitalization of $51.97 million, a price-to-earnings ratio of 13.40 and a beta of 0.37. The company has a current ratio of 2.11, a quick ratio of 1.61 and a debt-to-equity ratio of 0.69. The company has a 50-day moving average of $15.90 and a 200 day moving average of $15.90.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last posted its quarterly earnings results on Thursday, August 31st. The technology company reported $0.86 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 10.53% and a net margin of 1.81%. The business had revenue of $49.84 million for the quarter.
Wall Street Analysts Forecast Growth
Institutional Investors Weigh In On Kewaunee Scientific
Large investors have recently added to or reduced their stakes in the business. BlackRock Inc. increased its position in Kewaunee Scientific by 58.2% during the 2nd quarter. BlackRock Inc. now owns 13,102 shares of the technology company’s stock worth $198,000 after buying an additional 4,822 shares during the period. Renaissance Technologies LLC increased its position in Kewaunee Scientific by 0.7% during the 2nd quarter. Renaissance Technologies LLC now owns 98,111 shares of the technology company’s stock worth $1,631,000 after buying an additional 700 shares during the period. Vanguard Group Inc. increased its position in Kewaunee Scientific by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 126,581 shares of the technology company’s stock worth $1,836,000 after buying an additional 1,683 shares during the period. Minerva Advisors LLC increased its position in Kewaunee Scientific by 7.9% during the 4th quarter. Minerva Advisors LLC now owns 170,541 shares of the technology company’s stock worth $2,700,000 after buying an additional 12,474 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in Kewaunee Scientific by 0.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 185,989 shares of the technology company’s stock worth $3,273,000 after buying an additional 742 shares during the period. Institutional investors own 32.98% of the company’s stock.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
- Five stocks we like better than Kewaunee Scientific
- What is the S&P 500 and How It is Distinct from Other Indexes
- 2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
- Why Invest in High-Yield Dividend Stocks?
- Got Nuclear? Three Stocks To Play Energy’s Next Frontier
- What is a SEC Filing?
- The Top 4 Utilities for Value, Yield, and Upside Potential
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.